The Epstein-Barr virus (EBV) is an ubiquitous infectious agent which causes seroconversion with measurable antibody levels in approximately 90% of young children in tropical regions and 30-40% of children from developed countries in the Northern hemsiphere.' It is a member of the herpes virus family and has a double stranded DNA genome of 172 000 base pairs that is divided into five unique regions with internal repeat sequence of EBV DNA was present in the type II cells from patients with lymphocytic interstitial pneumonia but not those with fibrosing alveolitis whom they used as controls, suggests a discrepancy between the two studies that needs to be resolved. Experiments that examine lung tissue for viral DNA, RNA, and proteins will be needed to clarify why the EBV replicative proteins might be present when the internal repeat DNA is not.
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The observations reported by Egan et al are also of interest with respect to recent reports linking EBV infections to the development of benign and malignant smooth muscle tumours in children with AIDS8 and in patients immunosuppressed for transplantation.9 If EBV infection can transform smooth muscle cells and allow them to proliferate, it is also possible that it might transform fibroblasts and produce the connective tissue changes that characterise fibrosing alveolitis. The virus presumably infects epithelial cells first producing replicating infection, and the lymphocytes become infected as they circulate through the epithelium. Just how an infected epithelial cell or a lymphocyte might then infect and transform a smooth muscle cell89 or a fibroblast remains to be determined. In spite of these difficulties, the observation by Egan et al that the type II cell is infected by replicating EBV in patients with cytogenic fibrosing alveolitis provides an important new lead in the investigation of the process that deserves to be carefully followed up. Director 
